Clinical Trials Logo

Frailty clinical trials

View clinical trials related to Frailty.

Filter by:

NCT ID: NCT06309225 Not yet recruiting - Frailty Clinical Trials

Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly

(DACHOC-E)
Start date: March 30, 2024
Phase: N/A
Study type: Interventional

Previous studies of this type of head and necl cancer have shown high rates of cancer control but result in many short and long term side effects when treated with high dose radiation and chemotherapy. Recently, investigators have noticed similar high rates of cancer control in small numbers of patients who receive less intensive treatments using lower doses of radiation, smaller radiation fields with chemotherapy. It is expected that the side effects of treatment with lower doses of radiation would be less. For this reason this study is looking at a different regimen of reducing the intensity of the treatment. The purpose of this study is to compare any good and bad effects of using lower dose smaller fields radiation therapy and chemotherapy with published outcomes. This study will allow the researchers to know whether these different approaches are better, the same, or worse than the usual approach. To be better, the study approach should result in the same survival rate of the usual approach (about 85 out of 100 patients alive and free of cancer at 2 years) but with less long-term side effects.

NCT ID: NCT06281275 Not yet recruiting - Frailty Clinical Trials

A Study of the Association Between Frailty and Acute Postoperative Pain in Elderly Thoracoscopic Surgery Patients

Start date: April 12, 2024
Phase:
Study type: Observational

To gain a clearer understanding of the association between frailty and postoperative acute pain in elderly thoracoscopic surgery patients and its underlying mechanisms, to provide new solution ideas to reduce the level of postoperative acute pain and improve the debilitating state of elderly thoracoscopic surgery patients, and consequently improve their quality of life and mental status.

NCT ID: NCT06276166 Not yet recruiting - Frailty Clinical Trials

Trajectory of Frailty and Cognitive Dysfunction in Older Adults

Start date: March 15, 2024
Phase:
Study type: Observational

To explore the heterogeneity of the development trend of frailty and cognitive function of older adults.

NCT ID: NCT06271239 Not yet recruiting - Aging Clinical Trials

Effect of Multicomponent Exercises VIVIFRAIL® in Older Adults

Start date: March 15, 2024
Phase: N/A
Study type: Interventional

This study employs a randomized, controlled, paired, single-blind clinical trial design. The targeted demographic comprises individuals aged 60 and above. Following the initial assessment, participants will be randomly allocated to two groups: the Intervention Group (ViviFrail) and the Group Suggestions for a Healthy Life (CG), maintaining a 1:1 allocation ratio. Both the ViviFrail group and CG group will exhibit homogeneity in terms of their clinical characteristics and functional performance. The allocation of participants into respective groups will remain concealed from all assessors, ensuring a single-blind approach. In the intervention group (ViviFrail), 25 participants will be instructed to engage in tailored physical exercises outlined in the VIVIFRAIL® protocol within the confines of their homes, with adaptations made according to their clinical conditions and functional performance. Conversely, the Group Suggestions for a Healthy Life (CG) comprising 25 participants will receive exercise suggestions and guidance to maintain a healthy routine for a duration of three months. Subsequently, participants in the CG will undergo the VIVIFRAIL® program intervention for an additional three months.

NCT ID: NCT06270979 Not yet recruiting - Frailty Clinical Trials

Intrinsic Capacity and Functional Ability Monitoring With an Integrated Data Eco-System for Healthy Ageing.

ISHA
Start date: April 1, 2024
Phase:
Study type: Observational

In this study, 120 older adults (aged 65 years or older) either patients undergoing rehabilitation or older nursing home residents will be provided with an Eforto® device and the eco-System for Healthy Ageing (ISHA) mobile application to self-monitor intrinsic capacity for 4 months (if needed with assistance by an (in)formal caregiver). Preferably, the participants will use their own smartphone because mitigating smartphone-use-related issues. The aims of the study are: 1. to evaluate the usability and feasibility of self-monitoring intrinsic capacity by using the ISHA system in rehabilitation and nursing home settings. 2. to investigate if changes and variability in intrinsic capacity as measured with ISHA are related to changes in functional ability and quality of life. 3. to explore individual trajectories of intrinsic capacity with the ISHA system.

NCT ID: NCT06247189 Not yet recruiting - Multiple Myeloma Clinical Trials

ICOPE Program Feasibility in the Management of Myeloma Patients

Onco-ICOPE
Start date: September 1, 2024
Phase: N/A
Study type: Interventional

This project proposes to adapt monthly the existing ICOPE (Integrated Care for Older People) MONITOR program for elderly myeloma patients. This adaptation aims to detect earlier functional decline and prevent loss of autonomy.

NCT ID: NCT06244199 Not yet recruiting - Clinical trials for Cardiovascular Diseases

Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty

T2CR
Start date: June 1, 2024
Phase: Phase 2
Study type: Interventional

Cardiac rehabilitation (CR) is a secondary prevention program for patients with cardiovascular disease (CVD). It is especially valuable as CVD increasingly occurs in combination with comorbidity, frailty, and complexities of care that predispose patients to functional decline, disability, and high costs. Still, few Veterans participate in CR, in part because of the difficult logistics to attend. Promising Practice home-based CR (HBCR) was developed to increase CR participation, but many Veterans remain too limited by comorbidity and frailty for participation. A Transition to CR (T2CR) intervention is a face-to-face program that fosters vital skills, education, insights, motivation, and patient-provider relationships conducive to successful HBCR thereafter. This study compares Veterans eligible for CR who are randomized to T2CR intervention versus usual care. Differences in functional capacity, HBCR participation, and healthy days at home are compared over one year. Patients' experiences and providers' perspectives of barriers and facilitators to T2CR are also compared.

NCT ID: NCT06231576 Not yet recruiting - Surgery Clinical Trials

Digital Home-Based Prehabilitation Before Surgery

dHOPE
Start date: February 1, 2024
Phase: N/A
Study type: Interventional

This clinical trial compares two different prehabilitation programs, with no organized prehabilitation, prior to major colorectal cancer surgery. The prehabilitation programs include intensive and coached physical exercise and optimized nutritional intake coupled with smoking cessation, physiological support and correction of poly-pharmacy.

NCT ID: NCT06225271 Not yet recruiting - Frailty Clinical Trials

Effects of the Combined Intervention of Exercise, Fruit, and Vitamin Supplementation on Frailty in Older Adults

EFVF
Start date: February 25, 2024
Phase: N/A
Study type: Interventional

The goal of this cohort-based cluster-randomized controlled trial is to investigate the effect of the combined intervention of exercise, fruit, and vitamin supplementation on frailty among older adults. Older individuals aged 65~80 years old with low physical activity levels and low fruit intake will be recruited. 14 clusters will be randomized into 2 arms with 1:1 ratio. Participants in the intervention arm will receive the combined intervention of physical activity, fruit, and vitamin supplementation 3 times a week for 2 months (the 1st and 6th months). They will also be given group interventions, such as self-management group activity or health education, at least once a week. Participants in the control arm will not receive any intervention.

NCT ID: NCT06224556 Not yet recruiting - Older People Clinical Trials

A Personalized Prevention Program (PPP) Based on the Comprehensive Geriatric Assessment (CGA) for the Prevention of Multidimensional Frailty Related to Non-communicable Chronic Diseases (NCDs) in Older People

PrimaCare_P3
Start date: February 1, 2024
Phase: N/A
Study type: Interventional

- Non-Communicable Diseases (NCDs) can accelerated the aging process and increase the frailty condition - The Comprehensive Geriatric Assessment (CGA) is the gold standard in the geriatric clinical context - Recently, in Italy the first Guidelines about the CGA in different settings for older people has been pubblicated - The CGA can identify older people at high risk of frailty who can benefit from a personalized prevention program - No studies has been investigated the effects of a personalized prevention program (PPP) based on the CGA in a primary care setting - The main hypothesis is that the CGA assessment can result in personalized prevention programs for older subjects in primary care settings with an effect in reducing the hospitalization rate and can be related to the biological paramters in NCDs